Harrow Inc - Company Profile
Powered by 
All the sales intelligence you need on Harrow Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Harrow Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Harrow Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Harrow Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Harrow Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Mark L. Baum
Chief Executive Officer; Chairman Executive BoardMr. Mark L. Baum has been the Chairman and Chief Executive Officer of Harrow since 2011. Prior to this, he served as the Director at Chembio Diagnostic Systems, Inc., Applied Natural Gas Fuels, Inc., Shrink Nanotechnologies, Inc. and You on Demand, Inc. Previously, he served as the senior advisor at Curology.com from 2014 to 2017.
Andrew R. Boll
Secretary; Chief Financial Officer; President Senior ManagementMr. Andrew R. Boll has been the Chief Financial Officer, President and Corporate Secretary of the company since 2025. Prior to this, he served in various accounting roles at Welsh Companies, LLC.
Amir H. Shojaei, PhD
Chief Scientific Officer Senior ManagementDr. Amir H. Shojaei, PhD has been the Chief Scientific Officer of the company since January 2025. Prior to this, he served as the Chief Scientific Officer and Executive Vice President of Clinical Development at AsclepiX Therapeutics. Previously, he was the Chief Executive Officer at TherOptix Corporation. Mr. Shojaei also worked at Novartis Pharmaceuticals and Shire Pharmaceuticals.
Patrick W. Sullivan
Chief Commercial Officer Senior ManagementMr Patrick W. Sullivan has been the Chief Commercial Officer of the company since August 2025. Prior to this, he served as the Vice President at of Marketing, Neurology Portfolio at Corium Therapeutics. Previously, he served as the Global Commercial Head and Executive Director at AstraZeneca. He also served in various leadership roles at Shire, Adolor, Novartis, and Bayer.
Kim Barratt
Chief Talent Officer Senior ManagementMs. Kim Barratt has been the Chief Talent Officer of the company since 2022. Prior to this, she served as the Chief Human Resources Officer at Novatech. Previously, he served as the Executive Vice President of Operations at Skyway Studios. Mr Baratt served as the Chief Resource Officer at Fort Campbell Federal Credit Union and Manager at Learning and Development for Ingram Content Group.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer